Follow Us

Pfizer Vaccine Effective Against South African Variant

Pfizer says it will now apply for full FDA approval and submit its trial data for peer review.

Pfizer Vaccine Effective Against South African Variant

Mark Lennihan / AP

By Katherine Biek

Posted: 8:39 a.m. EDT Apr 1, 2021

Pfizer just announced this morning that its COVID vaccine is effective against the South African COVID variant.

That's according to its latest trial data.

The drugmaker said 12,000 participants in its Phase 3 clinical trial developed high levels of protection against the coronavirus six months after receiving their second dose.

Those high levels of protection extended to "currently circulating variants."

Pfizer says it will now apply for full FDA approval and submit its trial data for peer review.

Top Stories

A shearer breaks apart salvaged pieces of the collapsed Francis Scott Key Bridge

Crews race the clock to remove chunks of fallen Baltimore bridge

While clearing debris, salvage crews are also hoping to recover the remaining bodies of two construction workers who died in the collapse.

Supporters of Donald Trump participate in a rally in Washington, D.C., on Jan. 6, 2021.

Supreme Court hears debate over charges against Trump, Jan. 6 rioters

Justices will consider whether the charge of obstruction of an official proceeding can be used against those who protested Joe Biden's election win.

Paris Olympic flame is lit at ceremony in Greece

Paris Olympics flame is lit at the Greek cradle of ancient games

A relay of torchbearers will carry the flame more than 3,100 miles through Greece until the handover to Paris Games organizers in Athens.